businessinsider.com
Eli Lilly, the most valuable pharma company in the world, has decided to go cheap. (Well, sort of.)On Wednesday, when the $588 billion company debuted its powerful new weight loss drug, Zepbound, it did something unusual in the pharmaceutical world: It undercut the competition, pricing the shot almost 20% lower than Novo Nordisk’s Wegovy.Wegovy is the only other weekly injectable drug approved for weight loss. (Novo Nordisk’s Ozempic, which contains the same drug as Wegovy, is approved only for…
about 1 year ago